ATE294392T1 - Reagenz zur bestimmung von blutplättchen- mikroteilchen - Google Patents

Reagenz zur bestimmung von blutplättchen- mikroteilchen

Info

Publication number
ATE294392T1
ATE294392T1 AT01936518T AT01936518T ATE294392T1 AT E294392 T1 ATE294392 T1 AT E294392T1 AT 01936518 T AT01936518 T AT 01936518T AT 01936518 T AT01936518 T AT 01936518T AT E294392 T1 ATE294392 T1 AT E294392T1
Authority
AT
Austria
Prior art keywords
mpp
microparticles
platetic
reagent
determining
Prior art date
Application number
AT01936518T
Other languages
English (en)
Inventor
Michel Canton
Isabelle Botosezzy
Original Assignee
Biocytex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocytex filed Critical Biocytex
Application granted granted Critical
Publication of ATE294392T1 publication Critical patent/ATE294392T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/01—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials specially adapted for biological cells, e.g. blood cells
    • G01N2015/018—Platelets
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/1012—Calibrating particle analysers; References therefor
    • G01N2015/1014—Constitution of reference particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT01936518T 2000-05-16 2001-05-15 Reagenz zur bestimmung von blutplättchen- mikroteilchen ATE294392T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0006247A FR2809181B1 (fr) 2000-05-16 2000-05-16 Monoreactif pour le dosage des microparticules plaquettaires
PCT/FR2001/001468 WO2001088539A1 (fr) 2000-05-16 2001-05-15 Monoreactif pour le dosage des microparticules plaquettaires

Publications (1)

Publication Number Publication Date
ATE294392T1 true ATE294392T1 (de) 2005-05-15

Family

ID=8850288

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936518T ATE294392T1 (de) 2000-05-16 2001-05-15 Reagenz zur bestimmung von blutplättchen- mikroteilchen

Country Status (9)

Country Link
US (1) US20030175831A1 (de)
EP (1) EP1282817B1 (de)
JP (1) JP4831915B2 (de)
AT (1) ATE294392T1 (de)
CA (1) CA2410008A1 (de)
DE (1) DE60110407T2 (de)
ES (1) ES2238442T3 (de)
FR (1) FR2809181B1 (de)
WO (1) WO2001088539A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050222030A1 (en) * 2001-02-21 2005-10-06 Anthony Allison Modified annexin proteins and methods for preventing thrombosis
US7635680B2 (en) * 2001-02-21 2009-12-22 Alavita Pharmaceuticals, Inc. Attenuation of reperfusion injury
US20090291086A1 (en) * 2001-02-21 2009-11-26 Alavita Pharmaceuticals, Inc. Compositions and Methods for Treating Cerebral Thrombosis and Global Cerebral Ischemia
US7635676B2 (en) 2001-02-21 2009-12-22 Alavita Pharmaccuticals, Inc. Modified annexin proteins and methods for their use in organ transplantation
US7645739B2 (en) * 2001-02-21 2010-01-12 Alavita Pharmaceuticals, Inc. Modified annexin compositions and methods of using same
CN101068570A (zh) * 2004-05-13 2007-11-07 贝林格尔·英格海姆国际有限公司 双嘧达莫治疗血小板抑制剂的抗药性的用途
JP4029298B2 (ja) * 2004-07-26 2008-01-09 大塚製薬株式会社 粘着性マイクロベシクルの除去方法
US8900815B2 (en) 2005-02-21 2014-12-02 Saga University Platelet-derived microparticles as a novel diagnosis maker for a cardiovascular disease
GB2428471A (en) * 2005-07-18 2007-01-31 Mathshop Ltd Flow cytometry
SE531041C2 (sv) * 2006-07-17 2008-11-25 Hemocue Ab Räkning av trombocyter
FR2917172B1 (fr) * 2007-06-07 2014-01-03 Inst Nat Sante Rech Med Methode de mesure de l'activite plasmine des microparticules presentes dans un echantillon de fluide biologique et utilisation
WO2008157398A1 (en) 2007-06-13 2008-12-24 Litron Laboratories Ltd. Method for measuring in vivo hematotoxicity with an emphasis on radiation exposure assessment
JP2012168012A (ja) 2011-02-14 2012-09-06 Nippon Koden Corp 血管内皮障害を検査するための新規な検査方法および検査用キット
CN111929133A (zh) * 2011-11-30 2020-11-13 新加坡科技研究局 用于生物学检测的gm1神经节苷脂与膜联蛋白v的微粒多肽比例
CA3177929A1 (en) * 2012-12-21 2014-06-26 Astellas Institute For Regenerative Medicine Methods for production of platelets from pluripotent stem cells and compositions thereof
EP3213080B1 (de) * 2014-10-30 2019-04-24 Erasmus University Medical Center Rotterdam Reagenzien, verfahren und kits zur diagnose primärer immunschwächen
US11536709B2 (en) * 2016-03-30 2022-12-27 Siemens Healthcare Diagnostics Inc. Systems, methods, and apparatus for processing, organizing, and displaying platelet cell data
JP7376021B2 (ja) * 2018-06-07 2023-11-08 株式会社Ｌｓｉメディエンス ヒト血液からのマイクロベシクルの分離方法及び分析方法
JP7444386B2 (ja) * 2018-06-07 2024-03-06 株式会社Ｌｓｉメディエンス ヒト尿からのマイクロベシクルの分離方法及び分析方法
CN111896736A (zh) * 2020-08-04 2020-11-06 江西赛基生物技术有限公司 活化血小板的检测方法和检测试剂盒
WO2022132985A1 (en) * 2020-12-16 2022-06-23 Juno Therapeutics, Inc. Threshold gating for flow cytometry methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380663A (en) * 1984-12-24 1995-01-10 Caribbean Microparticles Corporation Automated system for performance analysis and fluorescence quantitation of samples
US4767206A (en) * 1984-12-24 1988-08-30 Flow Cytometry Standards Corporation Calibration method for flow cytometry using fluorescent microbeads and synthesis thereof
US5093234A (en) * 1984-12-24 1992-03-03 Caribbean Microparticles Corporation Method of aligning, compensating, and calibrating a flow cytometer for analysis of samples, and microbead standards kit therefor
CA2087086A1 (en) * 1992-01-22 1993-07-23 Leon Wmm Terstappen Multidimensional cell differential analysis
EP0685071A4 (de) * 1993-11-12 2000-12-13 Becton Dickinson Co Verfahren zu absoluter zählung von seltenen zellen
CA2185535C (en) * 1994-04-11 2000-10-24 Christiaan Peter Maria Reutelingsperger A method for detecting and/or optionally quantifying and/or separating apoptotic cells in or from a sample
US5552290A (en) * 1994-11-14 1996-09-03 University Of Massachusetts Medical Center Detection of procoagulant platelet-derived microparticles in whole blood
FR2795820A1 (fr) * 1999-07-01 2001-01-05 Biocytex Procede de quantification de microparticules endotheliales

Also Published As

Publication number Publication date
FR2809181A1 (fr) 2001-11-23
DE60110407D1 (de) 2005-06-02
JP2003533698A (ja) 2003-11-11
JP4831915B2 (ja) 2011-12-07
US20030175831A1 (en) 2003-09-18
EP1282817B1 (de) 2005-04-27
FR2809181B1 (fr) 2002-10-25
EP1282817A1 (de) 2003-02-12
DE60110407T2 (de) 2006-03-09
WO2001088539A1 (fr) 2001-11-22
ES2238442T3 (es) 2005-09-01
CA2410008A1 (fr) 2001-11-22

Similar Documents

Publication Publication Date Title
ATE294392T1 (de) Reagenz zur bestimmung von blutplättchen- mikroteilchen
BR0306589A (pt) Fotoproteìna com aperfeiçoada bioluminescência
DE69429770D1 (de) Verfahren und analytisches system zur genauen schnellen und einfachen ausführung von fibrinogen-assays
DE50304023D1 (de) Diagnose von Myokardinfarkt und akutem Koronarsyndrom durch Kombination von Markern
AU1038402A (en) Assay for directly detecting a rs virus related biological cell in a body fluid sample
ES2092596T3 (es) Indicadores de error de proteina de merocianina.
AU2003224447A1 (en) Device and method to simultaneously detect different antibodies and antigens in clinical alimentary and environmental samples
DE69840146D1 (de) Fluoreszenzprotein-sensoren zur erkennung von analyten
TW200720441A (en) New labelling strategies for the sensitive detection of analytes
ATE432358T1 (de) Kolorimetrische substrate, kolorimetrische sensoren und verwendungsverfahren
HUP9800008A2 (hu) Színezőreagens vérsejtek meghatározására
TR200103011T2 (tr) Bulaşıcı sünger tipi ansefalopatilerinin teşhisine yönelik metod.
BR0314155A (pt) Métodos para diagnosticar câncer cervical
ATE333510T1 (de) Enzymatische messung von mycophenolsäure
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
EP1214447B8 (de) Nachweis des pyruvatkinase-isoenzyms im stuhl
MXPA01006914A (es) Metodos para identificar combinaciones de entidades como terapeuticas.
AU5572998A (en) Improving performance of binding assays by use of more than one label
DE69732034D1 (de) Assay-verfahren
EP1536233A4 (de) Verfahren zur proteinbestimmung, indikator für die proteinbestimmung und teststück fur die proteinbestimmung
DE60014064D1 (de) Einetenascin-c isoform als marker für neoplasmen
ATE466284T1 (de) Bakterientestverfahren mit bindung einer intrazellularer enzyme
WO2006099537A3 (en) The use of antibody-surrogate antigen systems for detection of analytes
NO20052553L (no) Cobalaminanalyse.
ATE386935T1 (de) Verfahren zur auswahl bioaktiver wirkstoffe durch lumineszenzkopplung und lebendes zellensystem dafür

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties